Arena Pharma (ARNA) Balance Sheet

Click line-items for a historical chart and %

Assets
Cash and cash equivalents	101.63M
Accounts receivable	18.3M
Prepaid expenses and other current assets	4.77M
Total current assets	134.87M
Land, property and equipment, net	64.98M
Acquired technology and other intangibles, net
Other non-current assets	2.88M
Total assets	210.25M
Liabilities and Stockholders' Equity
Accounts payable and other accrued liabilities
Accrued compensation
Accrued clinical and preclinical study fees	6.53M
Accrued restructuring
Current portion of deferred revenues	22.52M
Current portion of derivative liabilities
Current portion of lease financing obligations
Total current liabilities	60.51M
Deferred rent
Deferred revenues, less current portion	82.13M
Derivative liabilities, less current portion
Lease financing obligations, less current portion
Commitments and contingencies and subsequent events	0
Stockholders' equity:
Common stock	24K
Additional paid-in capital	1.44B
Treasury stock, at cost
Accumulated other comprehensive income	867K
Accumulated deficit	-1.44B
Total stockholders' equity	3.33M
Total liabilities and stockholders' equity	210.25M
Siegfried [Member]
Liabilities and Stockholders' Equity
Current portion of note payable
Note payable
Deerfield [Member]
Liabilities and Stockholders' Equity
Current portion of note payable
Note payable

Entities mentioned with ARNA